The global burden of chromoblastomycosis.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
06
04
2021
accepted:
30
06
2021
entrez:
12
8
2021
pubmed:
13
8
2021
medline:
17
11
2021
Statut:
epublish
Résumé
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination. In order to estimate the global burden of CBM, we retrospectively reviewed the published literature from 1914 to 2020. Over the 106-year period, a total of 7,740 patients with CBM were identified on all continents except Antarctica. Most of the cases were reported from South America (2,619 cases), followed by Africa (1,875 cases), Central America and Mexico (1,628 cases), Asia (1,390 cases), Oceania (168 cases), Europe (35 cases), and USA and Canada (25 cases). We described 4,022 (81.7%) male and 896 (18.3%) female patients, with the median age of 52.5 years. The average time between the onset of the first lesion and CBM diagnosis was 9.2 years (range between 1 month to 50 years). The main sites involved were the lower limbs (56.7%), followed by the upper limbs (19.9%), head and neck (2.9%), and trunk (2.4%). Itching and pain were reported by 21.5% and 11%, respectively. Malignant transformation was described in 22 cases. A total of 3,817 fungal isolates were cultured, being 3,089 (80.9%) Fonsecaea spp., 552 (14.5%) Cladophialophora spp., and 56 Phialophora spp. (1.5%). This review represents our current knowledge on the burden of CBM world-wide. The global incidence remains unclear and local epidemiological studies are required to improve these data, especially in Africa, Asia, and Latin America. The recognition of CBM as NTD emphasizes the need for public health efforts to promote support for all local governments interested in developing specific policies and actions for preventing, diagnosing and assisting patients.
Sections du résumé
BACKGROUND
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
METHODS AND FINDINGS
In order to estimate the global burden of CBM, we retrospectively reviewed the published literature from 1914 to 2020. Over the 106-year period, a total of 7,740 patients with CBM were identified on all continents except Antarctica. Most of the cases were reported from South America (2,619 cases), followed by Africa (1,875 cases), Central America and Mexico (1,628 cases), Asia (1,390 cases), Oceania (168 cases), Europe (35 cases), and USA and Canada (25 cases). We described 4,022 (81.7%) male and 896 (18.3%) female patients, with the median age of 52.5 years. The average time between the onset of the first lesion and CBM diagnosis was 9.2 years (range between 1 month to 50 years). The main sites involved were the lower limbs (56.7%), followed by the upper limbs (19.9%), head and neck (2.9%), and trunk (2.4%). Itching and pain were reported by 21.5% and 11%, respectively. Malignant transformation was described in 22 cases. A total of 3,817 fungal isolates were cultured, being 3,089 (80.9%) Fonsecaea spp., 552 (14.5%) Cladophialophora spp., and 56 Phialophora spp. (1.5%).
CONCLUSIONS AND SIGNIFICANCE
This review represents our current knowledge on the burden of CBM world-wide. The global incidence remains unclear and local epidemiological studies are required to improve these data, especially in Africa, Asia, and Latin America. The recognition of CBM as NTD emphasizes the need for public health efforts to promote support for all local governments interested in developing specific policies and actions for preventing, diagnosing and assisting patients.
Identifiants
pubmed: 34383752
doi: 10.1371/journal.pntd.0009611
pii: PNTD-D-21-00489
pmc: PMC8360387
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009611Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lancet Infect Dis. 2017 Nov;17(11):e367-e377
pubmed: 28774696
Chemotherapy. 1992;38 Suppl 1:27-34
pubmed: 1319312
Ann Soc Belg Med Trop (1920). 1951 Oct;31(5):547-50
pubmed: 14915309
Bull Soc Pathol Exot Filiales. 1970 May-Jun;63(3):310-5
pubmed: 5537808
Med Mycol Case Rep. 2015 Sep 02;10:1-3
pubmed: 26484011
Ann Dermatol Venereol. 2014 May;141(5):396-8
pubmed: 24835659
Dermatol Online J. 2013 Nov 15;19(11):20394
pubmed: 24314771
Dermatol Online J. 2008 Feb 28;14(2):9
pubmed: 18700112
Australas J Dermatol. 1979 Apr;20(1):23-30
pubmed: 475694
Ann Soc Belg Med Trop (1920). 1952 Dec 31;32(5):491-500
pubmed: 13031302
Rev Chilena Infectol. 2017 Aug;34(4):404-407
pubmed: 29165523
J Fungi (Basel). 2020 Oct 03;6(4):
pubmed: 33022951
Bull Soc Pathol Exot Filiales. 1962 Sep-Oct;55:751-2
pubmed: 13992936
Southeast Asian J Trop Med Public Health. 2015 Jan;46(1):105-9
pubmed: 26513911
Arch Derm Syphilol. 1948 Feb;57(2):266-71
pubmed: 18912488
Ann Dermatol Venereol. 2010 Oct;137(10):591-6
pubmed: 20932437
Br J Dermatol. 1996 Jun;134 Suppl 46:33-6; discussion 40
pubmed: 8763467
AMA Arch Derm Syphilol. 1954 Jan;69(1):83-90
pubmed: 13113726
Emerg Infect Dis. 2020 Jun;26(6):1201-1211
pubmed: 32441639
Int J Dermatol. 1973 Nov-Dec;12(6):354-7
pubmed: 4797015
Bull Soc Pathol Exot Filiales. 1969 Nov-Dec;62(6):1054-63
pubmed: 5409181
Ann Dermatol Venereol. 2018 Aug - Sep;145(8-9):512-515
pubmed: 29779858
Cell Host Microbe. 2011 May 19;9(5):436-43
pubmed: 21575914
Int J Infect Dis. 2005 Sep;9(5):288-9
pubmed: 16098783
Bull Soc Pathol Exot Filiales. 1947;40(7-8):252
pubmed: 18903347
Dermatol Online J. 2005 Aug 01;11(2):14
pubmed: 16150222
S Afr Med J. 1962 Aug 11;36:647-50
pubmed: 13905116
Bull Soc Pathol Exot Filiales. 1978 Jan-Feb;71(1):63-70
pubmed: 719848
Sante. 1995 Jul-Aug;5(4):235-44
pubmed: 7582644
J Trop Med Hyg. 1983 Jun;86(3):109-11
pubmed: 6632031
BMC Infect Dis. 2011 Jan 12;11:14
pubmed: 21226934
Hand (N Y). 2018 Jul;13(4):384-390
pubmed: 28645215
Trans R Soc Trop Med Hyg. 2010 Feb;104(2):168-9
pubmed: 19766279
Am J Trop Med Hyg. 2010 Sep;83(3):448
pubmed: 20810801
Br J Dermatol. 2005 Mar;152(3):560-4
pubmed: 15787829
Ann Dermatol Venereol. 2006 Jan;133(1):68-9
pubmed: 16495858
J Natl Med Assoc. 1981 Mar;73(3):251-6
pubmed: 7009881
S Afr Med J. 1972 Nov 4;46(44):1679-81
pubmed: 4651722
Am J Trop Med Hyg. 1976 Jan;25(1):132-5
pubmed: 1259077
PLoS Negl Trop Dis. 2017 Apr 20;11(4):e0005492
pubmed: 28426666
Med Mycol. 2004 Jun;42(3):261-5
pubmed: 15283241
Ann Dermatol Venereol. 2008 Feb;135(2):111-5
pubmed: 18342091
An Fac Med Univ Repub Montev Urug. 1955 Mar-Apr;40(3-4):87-92
pubmed: 13292762
J Philipp Med Assoc. 1955 Mar;31(3):117-20
pubmed: 14368538
J Am Acad Dermatol. 2001 Apr;44(4):585-92
pubmed: 11260530
Mycopathologia. 1997;137(3):145-51
pubmed: 9368408
Mycoses. 2005 May;48(3):221-5
pubmed: 15842342
Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):391-8
pubmed: 24048727
Emerg Infect Dis. 2011 Mar;17(3):464-9
pubmed: 21392438
Arch Inst Pasteur Madagascar. 1981;48(1):69-95
pubmed: 7342901
Med Mycol. 2009 Feb;47(1):17-25
pubmed: 19107635
Med Mal Infect. 2018 Jun;48(4):278-285
pubmed: 29656841
Rev Soc Bras Med Trop. 1997 Jul-Aug;30(4):309-11
pubmed: 9265226
Mycopathol Mycol Appl. 1973 May 30;50(1):1-84
pubmed: 4711932
PLoS Negl Trop Dis. 2020 Jan 29;14(1):e0007999
pubmed: 31995572
Ann Soc Belges Med Trop Parasitol Mycol. 1967;47(3):249-56
pubmed: 5619092
Presse Med. 2015 Jul-Aug;44(7-8):842-3
pubmed: 26049906
Clin Infect Dis. 2014 Jun;58(12):1734-7
pubmed: 24633683
Ann Dermatol Venereol. 2013 Mar;140(3):197-201
pubmed: 23466152
Ann Soc Belges Med Trop Parasitol Mycol. 1970;50(2):205-9
pubmed: 5518951
Med Trop (Mars). 2003;63(6):614-6
pubmed: 15077427
Am J Trop Med Hyg. 1996 Jul;55(1):45-7
pubmed: 8702021
J Antimicrob Chemother. 2016 Dec;71(12):3599-3606
pubmed: 27516477
Bull Soc Pathol Exot Filiales. 1958 Nov-Dec;51(6):887-91
pubmed: 13662793
Mycoses. 2008 Jul;51(4):341-4
pubmed: 18444974
Med Mycol. 2004 Oct;42(5):405-16
pubmed: 15552642
Int J Dermatol. 1999 Apr;38(4):279-84
pubmed: 10321944
PLoS Negl Trop Dis. 2017 Aug 3;11(8):e0005534
pubmed: 28771470
Mycopathologia. 2019 Feb;184(1):115-119
pubmed: 29974323
Indian J Dermatol Venereol Leprol. 2007 May-Jun;73(3):176-8
pubmed: 17558050
Bull Soc Pathol Exot Filiales. 1963 Mar-Apr;56:117-9
pubmed: 14073518
Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1791-7
pubmed: 24832023
J Am Med Assoc. 1953 Oct 10;153(6):556
pubmed: 13084420
Ann Soc Belg Med Trop (1920). 1951 Aug;31(4):495-9
pubmed: 14878283
Bull Soc Pathol Exot Filiales. 1970 May-Jun;63(3):315-24
pubmed: 5537809
Med J Aust. 2012 Sep 17;197(6):350
pubmed: 22994835
Int J Dermatol. 1992 Nov;31(11):805-12
pubmed: 1330949
Mycoses. 2000;43(1-2):79-83
pubmed: 10838854
An Bras Derm Sifilogr. 1957 Dec;32(4):121-5
pubmed: 13583523
An Bras Dermatol. 2015 Jan-Feb;90(1):143
pubmed: 25672319
Ann Dermatol. 2011 Aug;23(3):369-74
pubmed: 21909211
Pathology. 2013 Aug;45(5):489-91
pubmed: 23856839
Bull Soc Pathol Exot Filiales. 1973 May-Jun;66(3):385-90
pubmed: 4801858
Pathology. 1996 May;28(2):182-7
pubmed: 8743828
Clin Microbiol Rev. 2017 Jan;30(1):233-276
pubmed: 27856522
Int J Dermatol. 1985 Jun;24(5):302-7
pubmed: 4018979
PLoS Negl Trop Dis. 2016 Nov 28;10(11):e0005102
pubmed: 27893750
Zhonghua Yi Xue Za Zhi (Taipei). 1995 Dec;56(6):432-5
pubmed: 8851486
Trop Geogr Med. 1989 Jul;41(3):222-6
pubmed: 2595799
Ethiop Med J. 1981 Jul;19(3):91-6
pubmed: 7285897
Med Sante Trop. 2013 May 1;23(2):145-57
pubmed: 23797833
Rev Med Hondur. 1956 Oct-Dec;24(4):112-7
pubmed: 13454024
Med Cutan Ibero Lat Am. 1984;12(5):430-8
pubmed: 6396470
Sem Hop. 1957 Feb 28;33(13/2):774-89
pubmed: 13421798
Mycopathol Mycol Appl. 1961 Aug 30;15:394-407
pubmed: 13695210
J Pak Med Assoc. 2019 Sep;69(9):1390-1393
pubmed: 31511733
JMM Case Rep. 2014 Dec 1;1(4):e004218
pubmed: 28663818
Arch Med Res. 2013 May;44(4):302-6
pubmed: 23684532
Rev Med Hondur. 1955 Aug-Oct;23(174):1019-57
pubmed: 13290300
Rev Med Liege. 1956 Nov 1;11(21):601-3
pubmed: 13390204
PLoS Negl Trop Dis. 2013 Nov 07;7(11):e2550
pubmed: 24244780
Mycopathologia. 2016 Jun;181(5-6):379-85
pubmed: 27025729
Med Mycol. 2018 Jun 1;56(4):395-405
pubmed: 29087525
Rev Clin Esp (Barc). 2014 Apr;214(3):e35
pubmed: 24439668
Int J Dermatol. 1984 May;23(4):273-4
pubmed: 6735554
J Trop Med Hyg. 1966 Aug;69(8):184-6
pubmed: 5920214
Trop Geogr Med. 1982 Mar;34(1):39-42
pubmed: 7080185
Med J Aust. 1947 Jan 18;1(3):93
pubmed: 20285426
Ann Soc Belg Med Trop (1920). 1952 Dec 31;32(5):417-9
pubmed: 13031295
Rev Cubana Med Trop. 1984 Jan-Apr;36(1):102-9
pubmed: 6390575
Clin Infect Dis. 2015 May 15;60(10):1500-4
pubmed: 25681378
Med Mycol. 2020 Feb 1;58(2):172-180
pubmed: 31329924
Skinmed. 2016 Dec 01;14(6):423-427
pubmed: 28031127
Australas J Dermatol. 1992;33(3):169-76
pubmed: 1303079
Mycopathologia. 1990 Jan;109(1):27-31
pubmed: 2325747
Int J Dermatol. 1983 May;22(4):221-9
pubmed: 6345416
J Health Care Poor Underserved. 2016;27(3):993-1010
pubmed: 27524747
Aust J Dermatol. 1952 Oct;1(4):207-13
pubmed: 13081515
Med Mycol. 2020 Nov 10;58(8):1044-1052
pubmed: 32242631
Arch Derm Syphilol. 1946 Sep;54:265-77
pubmed: 20996821
Arch Pathol Lab Med. 2013 Jun;137(6):798-804
pubmed: 23721275
Clin Exp Dermatol. 2018 Dec;43(8):925-927
pubmed: 29885020
Bull Soc Pathol Exot. 1997;90(5):312-7
pubmed: 9507759
Am J Med Sci. 2018 Mar;355(3):e7
pubmed: 29549935
Ann Dermatol Venereol. 2016 Dec;143 Suppl 3:S37-S42
pubmed: 29429508
Trop Med Infect Dis. 2019 Sep 24;4(4):
pubmed: 31554262
Int J Dermatol. 1988 Sep;27(7):481-4
pubmed: 3220630
S Afr Med J. 1955 Feb 19;29(8):186-8
pubmed: 14358886
Can Med Assoc J. 1950 Dec;63(6):595-6
pubmed: 14792443
AMA Arch Derm Syphilol. 1953 Feb;67(2):129-34
pubmed: 13029895
Rev Cubana Med Trop. 1978 May-Aug;30(2):95-108
pubmed: 368916
Bull Soc Pathol Exot Filiales. 1983 Nov;76(5):596-603
pubmed: 6673852
Mycologia. 1946 Jul-Aug;38(4):432-49
pubmed: 20992395
Rev Cubana Med Trop. 1979 Sep-Dec;31(3):217-24
pubmed: 399044
Cent Afr J Med. 1978 Oct;24(10):208-12
pubmed: 719735
Nouv Presse Med. 1974 Sep 21;3(31):1955
pubmed: 4444938
East Afr Med J. 1973 Aug;50(8):406-12
pubmed: 4761210
Acta Derm Venereol. 2005;85(3):259-60
pubmed: 16040416
Ann Dermatol Venereol. 2017 Jun - Jul;144(6-7):438-442
pubmed: 28396061
Mycopathologia. 2013 Jun;175(5-6):489-95
pubmed: 23086329
J Dermatol. 2020 Apr;47(4):409-412
pubmed: 31960479
An Bras Dermatol. 2016 Sep-Oct;91(5):679-681
pubmed: 27828652
Mycoses. 2005 Nov;48(6):456-61
pubmed: 16262887
Aust J Dermatol. 1952 Oct;1(4):214-22
pubmed: 13081516
Microbes Infect. 2005 Apr;7(4):708-13
pubmed: 15848277
Mycopathologia. 1998-1999;143(3):171-5
pubmed: 10353215
Int J Dermatol. 1971 Apr-Jun;10(2):118-25
pubmed: 5105128
Med Trop (Mars). 1990 Apr;50(2):195-6
pubmed: 2385164
Br J Dermatol. 2002 Apr;146(4):704
pubmed: 11966710
Clin Exp Dermatol. 2006 Mar;31(2):245-7
pubmed: 16487103
An Bras Dermatol. 2010 Jul-Aug;85(4):448-54
pubmed: 20944904
Rev Inst Med Trop Sao Paulo. 2005 Nov-Dec;47(6):339-46
pubmed: 16553324
Bull Soc Pathol Exot. 1991;84(3):247-56
pubmed: 1764753
S Afr Med J. 1949 Sep 3;23(36):736
pubmed: 18148449
Bull Soc Pathol Exot Filiales. 1958 Nov-Dec;51(6):884-7
pubmed: 13662792
Mycopathologia. 2013 Jun;175(5-6):477-88
pubmed: 23636730
Rev Fac Med Univ Nac Colomb. 1966 Jul-Sep;34(3):55-9
pubmed: 6015178
Int J Dermatol. 2011 Aug;50(8):981-6
pubmed: 21781072
Mycopathologia. 1983 May 22;82(2):111-3
pubmed: 6888499
Diagn Microbiol Infect Dis. 2019 Oct;95(2):201-207
pubmed: 31262546
J Dermatol. 2002 May;29(5):315-9
pubmed: 12081165
Med Trop (Mars). 2007 Feb;67(1):69-71
pubmed: 17506278
Clin Microbiol Infect. 2017 May;23(5):333.e9-333.e14
pubmed: 28062320
S Afr Med J. 1957 Jun 1;31(22):538-40
pubmed: 13442743
J Fungi (Basel). 2017 Oct 18;3(4):
pubmed: 29371573
Int J Dermatol. 2018 Nov;57(11):1351-1355
pubmed: 30113072